Medpace
Runs integrated Phase I–IV trials and laboratory services for drug and device developers.
$600.65
After-hours close+0.17 (+0.03%)
At close$600.48(−1.81%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Oct 2026 | $4.39 | — | — |
| Jul 2026 | $3.98 | $4.25 | +6.8% |
| Apr 2026 | $3.74 | $4.28 | +14.4% |
| Feb 2026 | $4.19 | $4.67 | +11.5% |
| Oct 2025 | $3.53 | $3.86 | +9.3% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Jul 2025 | |||
| Apr 2025 | |||
| Feb 2025 | |||
| Oct 2024 | |||
| Jul 2024 | |||
| Apr 2024 | |||
| Feb 2024 | |||
| Oct 2023 | |||
| Jul 2023 | |||
| Apr 2023 | |||
| Feb 2023 | |||
| Oct 2022 | |||
| Jul 2022 | |||
| Apr 2022 | |||
| Feb 2022 | |||
| Oct 2021 | |||
| Jul 2021 | |||
| Apr 2021 | |||
| Feb 2021 | |||
| Oct 2020 | |||
| Jul 2020 | |||
| Apr 2020 | |||
| Feb 2020 | |||
| Oct 2019 | |||
| Jul 2019 | |||
| Apr 2019 | |||
| Feb 2019 | |||
| Oct 2018 | |||
| Jul 2018 | |||
| Apr 2018 | |||
| Feb 2018 | |||
| Oct 2017 | |||
| Jul 2017 | |||
| May 2017 | |||
| Feb 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| Jun 2016 | |||
| Dec 2015 | |||
| Sep 2015 | |||
| Jun 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Oct 28, 2026 | $4.39 | — | — | $714.3M | — | — |
| Jul 22, 2026 | $3.98 | $4.25 | +6.8% | $689.5M | $707.3M | +2.6% |
| Apr 22, 2026 | $3.74 | $4.28 | +14.4% | $697.6M | $706.6M | +1.3% |
| Feb 9, 2026 | $4.19 | $4.67 | +11.5% | $689.3M | $708.5M | +2.8% |
| Oct 22, 2025 | $3.53 | $3.86 | +9.3% | $641.0M | $659.9M | +2.9% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Jul 21, 2025 | ||||||
| Apr 21, 2025 | ||||||
| Feb 10, 2025 | ||||||
| Oct 21, 2024 | ||||||
| Jul 22, 2024 | ||||||
| Apr 22, 2024 | ||||||
| Feb 12, 2024 | ||||||
| Oct 23, 2023 | ||||||
| Jul 24, 2023 | ||||||
| Apr 24, 2023 | ||||||
| Feb 13, 2023 | ||||||
| Oct 24, 2022 | ||||||
| Jul 25, 2022 | ||||||
| Apr 25, 2022 | ||||||
| Feb 14, 2022 | ||||||
| Oct 25, 2021 | ||||||
| Jul 26, 2021 | ||||||
| Apr 26, 2021 | ||||||
| Feb 15, 2021 | ||||||
| Oct 26, 2020 | ||||||
| Jul 27, 2020 | ||||||
| Apr 28, 2020 | ||||||
| Feb 24, 2020 | ||||||
| Oct 28, 2019 | ||||||
| Jul 29, 2019 | ||||||
| Apr 29, 2019 | ||||||
| Feb 25, 2019 | ||||||
| Oct 29, 2018 | ||||||
| Jul 30, 2018 | ||||||
| Apr 30, 2018 | ||||||
| Feb 26, 2018 | ||||||
| Oct 30, 2017 | ||||||
| Jul 31, 2017 | ||||||
| May 1, 2017 | ||||||
| Feb 27, 2017 | ||||||
| Nov 3, 2016 | ||||||
| Aug 16, 2016 | ||||||
| Jun 30, 2016 | ||||||
| Dec 31, 2015 | ||||||
| Sep 30, 2015 | ||||||
| Jun 30, 2015 | ||||||